Delivery Order SPE2DB22D2206-SPE2DB25FGP93

Award Date 4/16/25
Potential Completion Date 5/7/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $13,259.50 and has a period of performance through March 4, 2025. The contract is for the supply of the pharmaceutical product SCEMBLIX 40 MG TABLET, which is likely used for various medical treatments. This delivery order contract is associated with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product, with a ceiling value of $13,259.50. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 6, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,259.50 fixed-price contract is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a specialty medication. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SCEMBLIX 40 MG TABLET, a specialty medication, with a ceiling value of $26,519.00 and a period of performance through April 2, 2025. The contract is a firm-fixed-price, non-set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of SCEMBLIX 20 MG TABLET medical products, with a ceiling value of $12,224.42 and an ultimate completion date of August 13, 2024. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,519.00, is a delivery order for the medication SCEMBLIX 40 MG TABLET, with a performance period extending through May 7, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and has no listed...
This federal contract award, valued at $24,304.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the drug product SCEMBLIX 40 MG TABLET. It is a firm-fixed-price contract with a completion date of November 25, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $26,519.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 7, 2025. The contract covers the procurement of SCEMBLIX 40 MG TABLET UU 60S, a pharmaceutical product, to support military treatment facilities, veterans' healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,637.88 firm fixed-price delivery order is for the supply of 60 tablets of SCEMBLIX 20 MG, a pharmaceutical product. The award has an ultimate completion date of January 24, 2025 and was made on January 2, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $24,448.84 firm fixed-price contract is for the supply of 4565697668 SCEMBLIX 20 MG TABLET UU 60S, a pharmaceutical product. The award has an ultimate completion date of September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by various agencies to...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGP93
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SCEMBLIX 40 MG TABLET medication, with a firm fixed price of $13,259.50 and a period of performance through May 7, 2025. The contract is not set aside for any specific business type.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is likely a part of that larger IDC, enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other government agency requirements.

Generated 7/16/25, 12:22 PM